BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9645049)

  • 1. [Vitamin B1 dependency].
    Kuroda Y; Naito E
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):225-8. PubMed ID: 9645049
    [No Abstract]   [Full Text] [Related]  

  • 2. Thiamine-responsive inborn errors of metabolism.
    Duran M; Wadman SK
    J Inherit Metab Dis; 1985; 8 Suppl 1():70-5. PubMed ID: 3930844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Maple syrup urine disease].
    Indo Y; Matsuda I
    Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):201-4. PubMed ID: 9590028
    [No Abstract]   [Full Text] [Related]  

  • 4. [Maple syrup urine disease].
    Indo Y
    Nihon Rinsho; 2002 Apr; 60 Suppl 4():783-7. PubMed ID: 12013999
    [No Abstract]   [Full Text] [Related]  

  • 5. Thiamine response in maple syrup urine disease.
    Fernhoff PM; Lubitz D; Danner DJ; Dembure PP; Schwartz HP; Hillman R; Bier DM; Elsas LJ
    Pediatr Res; 1985 Oct; 19(10):1011-6. PubMed ID: 3903643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Maple syrup urine disease].
    Matsuda I
    Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):585-8. PubMed ID: 3270867
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of thiamin in maple syrup urine disease.
    Elsas LJ; Danner DJ
    Ann N Y Acad Sci; 1982; 378():404-21. PubMed ID: 7044230
    [No Abstract]   [Full Text] [Related]  

  • 8. A nonsense mutation (R242X) in the branched-chain alpha-keto acid dehydrogenase E1alpha subunit gene (BCKDHA) as a cause of maple syrup urine disease. Mutations in brief no. 160. Online.
    Chinsky J; Appel M; Almashanu S; Costeas P; Ambulos N; Carmi R
    Hum Mutat; 1998; 12(2):136. PubMed ID: 10694918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and biochemical basis of intermediate maple syrup urine disease. Occurrence of homozygous G245R and F364C mutations at the E1 alpha locus of Hispanic-Mexican patients.
    Chuang JL; Davie JR; Chinsky JM; Wynn RM; Cox RP; Chuang DT
    J Clin Invest; 1995 Mar; 95(3):954-63. PubMed ID: 7883996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Increasing the effectiveness of thiamine by its administration together with methionine and vitamin E].
    Parkhomenko IuM; Chernysh IIu; Protasova ZS; Donchenko GV
    Vopr Pitan; 1992; (1):45-8. PubMed ID: 1621378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maple syrup urine disease in a Bedouin tribe: pre- and postnatal diagnosis.
    Potashnik R; Carmi R; Sofer S; Bashan N; Abeliovich D
    Isr J Med Sci; 1987 Aug; 23(8):886-9. PubMed ID: 3679791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of thiamine treatment in a child with Leigh disease due to thiamine-responsive pyruvate dehydrogenase deficiency.
    Di Rocco M; Lamba LD; Minniti G; Caruso U; Naito E
    Eur J Paediatr Neurol; 2000; 4(3):115-7. PubMed ID: 10872106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical basis of thiamin-responsive maple syrup urine disease.
    Chuang DT; Ku LS; Cox RP
    Trans Assoc Am Physicians; 1982; 95():196-204. PubMed ID: 7182976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maple syrup urine disease 1954 to 1993.
    Peinemann F; Danner DJ
    J Inherit Metab Dis; 1994; 17(1):3-15. PubMed ID: 8051937
    [No Abstract]   [Full Text] [Related]  

  • 15. A structural abnormality of E1 component of the branched-chain alpha-keto acid dehydrogenase complex in maple syrup urine disease.
    Indo Y; Kitano A; Akaboshi I; Endo F; Matsuda I
    J Inherit Metab Dis; 1987; 10(3):281-3. PubMed ID: 3123794
    [No Abstract]   [Full Text] [Related]  

  • 16. Enzymatic method for branched chain alpha-ketoacid determination: application to rapid analysis of urine and plasma samples from maple syrup urine disease patients.
    Burgos C; Civallero GE; de Kremer RD; Gerez de Burgos NM; Blanco A
    Acta Physiol Pharmacol Ther Latinoam; 1999; 49(2):109-17. PubMed ID: 10797848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maple syrup urine disease: clinical and biochemical significance of gene analysis.
    Nobukuni Y; Mitsubuchi H; Akaboshi I; Indo Y; Endo F; Matsuda I
    J Inherit Metab Dis; 1991; 14(5):787-92. PubMed ID: 1664011
    [No Abstract]   [Full Text] [Related]  

  • 18. Enzyme assays with mutant cell lines of maple syrup urine disease.
    Chuang DT; Cox RP
    Methods Enzymol; 1988; 166():135-46. PubMed ID: 3071697
    [No Abstract]   [Full Text] [Related]  

  • 19. Maple syrup urine disease: metabolic decompensation monitored by proton magnetic resonance imaging and spectroscopy.
    Felber SR; Sperl W; Chemelli A; Murr C; Wendel U
    Ann Neurol; 1993 Apr; 33(4):396-401. PubMed ID: 8489211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of common ancestry for the maple syrup urine disease (MSUD) Y438N allele in non-Mennonite MSUD patients.
    Love-Gregory LD; Grasela J; Hillman RE; Phillips CL
    Mol Genet Metab; 2002 Jan; 75(1):79-90. PubMed ID: 11825067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.